ERCC2 and non-small cell lung carcinoma: A meta-analysis of clinical studies has shown that ERCC2 rs13181 with A/C and C/C genotypes is associated with low sensitivity in Asian populations and with high sensitivity in Caucasian NSCLC patients that were treated with platinum drugs [53].